Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher B Granger

Showing results (351-360 of 910) with videos related to

Pageof 91
Sort By:
European Heart Journal|October 13, 2005
Predictors of mortality and morbidity in patients with chronic heart failureStuart J Pocock, Duolao Wang, Marc A Pfeffer, et al.
Journal of the American College of Cardiology|August 28, 2024
Antithrombotic Strategies in Atrial Fibrillation After ACS and/or PCI: A 4-Way Comparison From AUGUSTUSOtavio Berwanger, Daniel M Wojdyla, Alexander C Fanaroff, et al.
American Heart Journal|May 26, 2009
Validity of a risk-prediction tool for hospital mortality: the Global Registry of Acute Coronary EventsKaren S Pieper, Joel M Gore, Gordon FitzGerald, et al.
Journal of Thrombosis and Haemostasis : JTH|August 14, 2021
Multiplex protein screening of biomarkers associated with major bleeding in patients with atrial fibrillation treated with oral anticoagulationAgneta Siegbahn, Johan Lindbäck, Ziad Hijazi, et al.
American Heart Journal|March 29, 2023
Individual net clinical outcome with oral anticoagulation in atrial fibrillation using the ABC-AF risk scoresZiad Hijazi, Johan Lindbäck, Jonas Oldgren, et al.
Circulation|November 21, 2007
Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction?Frederick A Spencer, Mauro Moscucci, Christopher B Granger, et al.
Diabetes Care|February 7, 2009
Predictors of development of diabetes in patients with chronic heart failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) programDavid Preiss, Sofia Zetterstrand, John J V McMurray, et al.
European Journal of Heart Failure|January 24, 2014
Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-PreservedJennifer K Rogers, Stuart J Pocock, John J V McMurray, et al.
JACC. Clinical Electrophysiology|March 6, 2026
Center-Level Factors and Geographic Variation in Treatment of Cardiovascular Implantable Electronic Device InfectionsEthan S Wagner, Lindsay Zepel, Robert K Lewis, et al.
Circulation. Cardiovascular Interventions|July 18, 2013
Bypassing the emergency department and time to reperfusion in patients with prehospital ST-segment-elevation: findings from the reperfusion in acute myocardial infarction in Carolina Emergency Departments projectAkshay Bagai, Hussein R Al-Khalidi, Daniel Muñoz, et al.
Pageof 91

Showing results (351-360 of 910) with videos related to

Sort By:
Pageof 91
European Heart Journal|October 13, 2005
Predictors of mortality and morbidity in patients with chronic heart failureStuart J Pocock, Duolao Wang, Marc A Pfeffer, et al.
Journal of the American College of Cardiology|August 28, 2024
Antithrombotic Strategies in Atrial Fibrillation After ACS and/or PCI: A 4-Way Comparison From AUGUSTUSOtavio Berwanger, Daniel M Wojdyla, Alexander C Fanaroff, et al.
American Heart Journal|May 26, 2009
Validity of a risk-prediction tool for hospital mortality: the Global Registry of Acute Coronary EventsKaren S Pieper, Joel M Gore, Gordon FitzGerald, et al.
Journal of Thrombosis and Haemostasis : JTH|August 14, 2021
Multiplex protein screening of biomarkers associated with major bleeding in patients with atrial fibrillation treated with oral anticoagulationAgneta Siegbahn, Johan Lindbäck, Ziad Hijazi, et al.
American Heart Journal|March 29, 2023
Individual net clinical outcome with oral anticoagulation in atrial fibrillation using the ABC-AF risk scoresZiad Hijazi, Johan Lindbäck, Jonas Oldgren, et al.
Circulation|November 21, 2007
Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction?Frederick A Spencer, Mauro Moscucci, Christopher B Granger, et al.
Diabetes Care|February 7, 2009
Predictors of development of diabetes in patients with chronic heart failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) programDavid Preiss, Sofia Zetterstrand, John J V McMurray, et al.
European Journal of Heart Failure|January 24, 2014
Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-PreservedJennifer K Rogers, Stuart J Pocock, John J V McMurray, et al.
JACC. Clinical Electrophysiology|March 6, 2026
Center-Level Factors and Geographic Variation in Treatment of Cardiovascular Implantable Electronic Device InfectionsEthan S Wagner, Lindsay Zepel, Robert K Lewis, et al.
Circulation. Cardiovascular Interventions|July 18, 2013
Bypassing the emergency department and time to reperfusion in patients with prehospital ST-segment-elevation: findings from the reperfusion in acute myocardial infarction in Carolina Emergency Departments projectAkshay Bagai, Hussein R Al-Khalidi, Daniel Muñoz, et al.
Pageof 91